Related references
Note: Only part of the references are listed.Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis
Philipp Erben et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria
Martha Wadleigh et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms Order Out of Chaos
Ayalew Tefferi et al.
CANCER (2009)
Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
Ayalew Tefferi
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders
Nicholas C. P. Cross et al.
ACTA HAEMATOLOGICA (2008)
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β gene
Christoph Walz et al.
HAEMATOLOGICA (2007)
Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders
Andreas Reiter et al.
CURRENT DRUG TARGETS (2007)
Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders
Marianna David et al.
BLOOD (2007)
Oncogenic derivatives of platelet-derived growth factor receptors
AV Jones et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders
A Pardanani et al.
LEUKEMIA RESEARCH (2004)
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta
JL Garcia et al.
BLOOD (2003)
Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders
EJ Baxter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
JF Apperley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tyrosine kinase fusion genes in chronic myeloproliferative diseases
NCP Cross et al.
LEUKEMIA (2002)
Myeloproliferative disorders with translocations of chromosome 5q31-35: Role of the platelet-derived growth factor receptor beta
EJ Steer et al.
ACTA HAEMATOLOGICA (2002)
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia
JM Hernández et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
